- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03287739
Recovery of Impairments Early After Stroke (aRISE)
Upper limb recovery after stroke is highly predictable early after stroke. Nijland et al. showed that based on two simple clinical bedside tests - 'Shoulder Abduction' and 'Finger Extension' (the so called 'SAFE model' [Stinear et al., 2012]) - measured within the first 72 hours after stroke, ~87% of the patients could be correctly classified as either regaining or not regaining some dexterity (recoverers or nonrecoverers, respectively) (Nijland et al., 2010). This kind of information regarding the patients' functional prognosis allows proper discharge planning, setting realistic rehabilitation goals, and adequate patient information. However, the length of hospital stay after stroke has been decreasing. Therefore, knowledge is needed regarding the ability to make an accurate first prediction within the first 24 hours after stroke onset while using simple clinical bedside assessments. This would facilitate an earlier triage and with that, an accelerated and smooth transition of patients within the stroke care continuum. In addition, a first prediction within 24 hours poststroke has the potential to decrease health care expenses, as length of hospital stay after an acute stroke is ~30% of the total costs (i.e., direct and indirect costs) associated with stroke (Roger et al., 2012; Fattore et al., 2012).
The primary objective of aRISE is to determine the ability of the behavioral biometric impairments 'Shoulder Abduction' and 'Finger Extension' measured <24 hours poststroke to predict outcome of upper limb capacity 3 months after stroke. The secondary aim is to investigate the the added value of other simple clinical bedside tests for predicting outcome of upper limb capacity 3 months poststroke.
aRISE is a prospective longitudinal observational cohort study of 40 first-ever ischemic stroke patients, who will be assessed <24 hours, 7 days and 3 months after stroke onset.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Zurich, Schweiz, 8091
- University of Zurich
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- First-ever unilateral ischemic stroke in the middle cerebral artery territory <48 hours, confirmed by MRI-DWI and/or CT
- Age 18 years or older
- Able to follow one-staged commands
- NIHSS arm score ≥1
- Informed consent after participants' information
Exclusion Criteria:
- Modified Rankin Scale score >2 before stroke
- Neurological or other diseases affecting the upper limb(s) before stroke
- Intravenous line in the upper limb(s) which limits assessment
- Contra-indications on ethical grounds
- Expected or known non-compliance to participate in the observational study, severe drug or/and alcohol abuse
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Kohort
- Tidsperspektiv: Blivande
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Single-group study
Assessment of behavioral biometric impairments
|
Assessment of behavioral biometric impairments
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Action Research Arm Test
Tidsram: 3 months poststroke
|
Upper limb capacity
|
3 months poststroke
|
|
Fugl-Meyer Assessment
Tidsram: 3 months poststroke
|
Upper limb motor function
|
3 months poststroke
|
|
Motricity Index
Tidsram: 3 months poststroke
|
Upper limb motor function
|
3 months poststroke
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Surface Electromyography
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Forearm skeletal muscle electric activity
|
48 hours, 7 days, and 3 months poststroke
|
|
Movement Sensors
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Upper limb range of motion patterns
|
48 hours, 7 days, and 3 months poststroke
|
|
National Institutes of Health Stroke Scale
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Neurological functions
|
48 hours, 7 days, and 3 months poststroke
|
|
Trunk Control Test
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Sitting balance
|
48 hours, 7 days, and 3 months poststroke
|
|
Functional Ambulation Categories
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Walking ability (independence)
|
48 hours, 7 days, and 3 months poststroke
|
|
Modified Rankin Scale
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Global disability
|
48 hours, 7 days, and 3 months poststroke
|
|
Motor Activity Log - 14
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Patient-reported daily life upper limb use
|
48 hours, 7 days, and 3 months poststroke
|
|
Global Rating of Perceived Changes
Tidsram: 3 months poststroke
|
3 months poststroke
|
|
|
Concomitant Movement Therapy
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Intensity of therapy based on charts
|
48 hours, 7 days, and 3 months poststroke
|
|
Safety
Tidsram: 48 hours, 7 days, and 3 months poststroke
|
Serious Events (1.
death; 2. life-threatening illness or injury; 3. in-patient or prolonged hospitalisation; 4. medical or surgical intervention to prevent life threatening illness; 5. led to fetal distress, death or a congenital abnormality or birth defect)
|
48 hours, 7 days, and 3 months poststroke
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Allmänna publikationer
- Fattore G, Torbica A, Susi A, Giovanni A, Benelli G, Gozzo M, Toso V. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol. 2012 Nov 14;12:137. doi: 10.1186/1471-2377-12-137.
- Nijland RH, van Wegen EE, Harmeling-van der Wel BC, Kwakkel G; EPOS Investigators. Presence of finger extension and shoulder abduction within 72 hours after stroke predicts functional recovery: early prediction of functional outcome after stroke: the EPOS cohort study. Stroke. 2010 Apr;41(4):745-50. doi: 10.1161/STROKEAHA.109.572065. Epub 2010 Feb 18.
- Stinear CM, Barber PA, Petoe M, Anwar S, Byblow WD. The PREP algorithm predicts potential for upper limb recovery after stroke. Brain. 2012 Aug;135(Pt 8):2527-35. doi: 10.1093/brain/aws146. Epub 2012 Jun 10.
- Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15. No abstract available. Erratum In: Circulation. 2012 Jun 5;125(22):e1002.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2017-00889
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Assessment of behavioral biometric impairments
-
Eunice Kennedy Shriver National Institute of Child...Avslutad
-
CelgeneAvslutadMyelodysplastiska syndrom | Multipelt myelom | Leukemi Myeloid Akut | Leuklemi, lymfocytisk, kroniskSpanien
-
Maastricht UniversityTNO; Netherlands Instititute for Health Services Research; University of...AvslutadHjärtsvikt | Diabetes mellitus, typ 2 | Kronisk obstruktiv lungsjukdom | AstmaNederländerna
-
Assistance Publique - Hôpitaux de ParisHar inte rekryterat ännuHörselnedsättning | Kognitiv funktion | Verkställande funktion | Vestibulär funktionFrankrike
-
Memorial Sloan Kettering Cancer CenterAvslutadFamiljer eller anhöriga till patienter som behandlas vid MSKCC för icke-kutana skivepitelcancer i | Övre matsmältningskanalenFörenta staterna
-
Rhode Island HospitalAvslutadHIV | Medicinering vidhäftning | Mobil hälsaFörenta staterna
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandAvslutadAnatomi hos ductus venosus | Umbilikal VenkateteriseringPolen
-
University of MiamiRekrytering
-
University of Wisconsin, MadisonAvslutadAchilles tendinitFörenta staterna
-
Duke UniversityNational Institute of Mental Health (NIMH)AvslutadSjälvmordFörenta staterna